Is Your Out-of-Network Claim Even Eligible for IDR? A Specialty-by-Specialty Guide

A practice with out-of-network claims does everything right. The claim goes out, the payer underpays, the billing team sends the open negotiation notice, thirty business days pass without resolution, and the case moves to a certified IDR entity. Six to eight weeks later, the answer comes back: ineligible. Not underpaid. Not undervalued. Ineligible, meaning it never should have entered the Federal Independent Dispute Resolution process at all.

That outcome is not a rare edge case. Roughly one in five closed disputes has been thrown out as ineligible in every year the Federal IDR process has operated: about 22 percent in 2023, 19 percent in 2024, and 17 percent in the first half of 2025. Payers challenge the eligibility of a much larger share, around 40 percent of all disputes, meaning nearly half of everything filed gets a formal ineligibility argument raised against it before anyone even discusses payment. Between April 2022 and the end of 2024, payers challenged the eligibility of 976,721 disputes, and certified IDR entities agreed with those challenges often enough to close out 355,804 of them. In some of the litigation now working through federal courts, the numbers are starker still. Anthem alleges that 55 percent of one high volume filer's submissions were ineligible, and in a separate suit, Anthem's Virginia affiliate alleges that close to 60 percent of more than 27,000 disputes filed against it since 2024 didn't belong in the federal process, including one day where a single filer submitted 954 disputes, of which the payer says 943 were ineligible.

Those are not stories about consent forms. They are stories about network status, timing, and jurisdiction: the unglamorous, mechanical parts of a claim that determine whether it ever had a legitimate seat at the table.

The assumption that causes the problem

Most practices treat "out-of-network" and "IDR eligible" as the same thing. They are not. A claim only reaches the Federal IDR process if it clears several distinct, and mostly procedural, tests. CMS itself has said that sorting out which claims clear those tests has become so resource-intensive that it now consumes more certified IDR entity time than the payment determination itself. That's exactly what the Departments tried to address in the Federal IDR Operations final rule released in May 2026. Worth noting briefly, and then moving past: one of the theoretical off-ramps from IDR eligibility is a signed notice and consent waiver, in which a patient agrees in advance to waive balance billing protection for certain non-emergency services. It exists as a factor. It is also, by every account from insurers who monitor for it, rarely used: one 2023 research consortium reported that payers "do not appear to be asking many patients to sign consent waivers" at all. It is not where the volume of ineligible claims is coming from. The real causes are structural.

Network status: the contractual relationship most billing teams never actually check

The single most consequential, and least understood, eligibility test isn't about where the service happened. It's about whether the specific clinician who rendered it had a contract with that specific payer at the time. The No Surprises Act only applies to a "nonparticipating provider," a legal and contractual determination, not an operational one. A practice can be credentialed and in-network under its group TIN while the individual rendering physician (a locum, a new hire mid-enrollment, a physician added to a coverage panel) is not yet enrolled with that plan. Depending on how the payer's systems treat that gap, the claim may get adjudicated and paid as in-network on one end, while the practice's billing team treats it as an out-of-network NSA claim on the other. When the two don't match, the dispute isn't really about the amount owed: it's about whether the claim ever qualified as a nonparticipating claim in the first place, and that question alone can sink it in eligibility review before a payment number is ever discussed.

This is not a theoretical concern regulators invented to fill a rulemaking. It's serious enough that the May 2026 final rule now requires payers to flag, on every remittance advice sent to a provider without a contractual relationship, whether that specific claim is or isn't subject to the NSA, using standardized claim adjustment and remark codes rather than leaving providers to infer it. A federal rule doesn't get built around a rare problem. This gap between TIN level network status and individual level contractual status is a routine, recurring reason claims never should have gone to IDR, particularly for hospital-based and staffing-heavy specialties (emergency medicine, anesthesiology, radiology, hospitalist, and pathology groups) where locum coverage, credentialing lag, and multi-payer panels churn constantly.

Timing: the procedural clock nobody documented

The No Surprises Act gives disputing parties a 30 business day open negotiation period before IDR becomes available, and requires the party initiating IDR to do so within 4 business days after that period ends. Historically, there was no consistent, portal-documented way to prove when that clock actually started or whether real negotiation occurred: parties often asserted an open negotiation period had run its course with little more than an email trail to show for it. CMS has identified untimely initiation and incomplete open negotiation as recurring, named reasons disputes get tossed. The May 2026 rule tightens this considerably. The open negotiation notice must now go through the Federal IDR portal to both the other party and the Departments, and the party receiving it must file a documented response by the fifteenth business day. That change exists because the informal version of this process was generating enough ineligible filings to warrant a federal fix.

Jurisdiction: whose process actually governs this claim

Twenty two states have their own laws governing out-of-network payment disputes for fully insured plans, and a specified state law or All-Payer Model Agreement preempts the federal methodology whenever it applies. Whether a given claim belongs in the state system or the federal one depends on the state, the type of plan, and, critically, whether the plan is self-funded under ERISA, which covers 63 percent of workers with employer-sponsored coverage and generally falls under federal jurisdiction regardless of state law. States with bifurcated systems illustrate how large this gap can run in practice. Virginia's state-level IDR process handled just 252 cases in a recent one-year period, while more than 34,000 Virginia-related disputes were filed in the federal system over roughly the same span. A practice that doesn't check plan funding status and state law applicability before filing isn't making a specialty-specific mistake. It's making a jurisdictional one, and it's a mistake happening at scale.

Batching: the grouping error CMS calls out by name

Federal IDR allows disputing parties to batch multiple claims into a single filing to reduce administrative cost, but the batching rules are specific about what can be grouped together: the same patient encounter, comparable service codes, or, for certain specialties, codes within the same CPT Category I section. CMS has named incorrect batching directly as a driver of ineligible determinations, citing cases where claims paid by different plans or issuers were combined into a single batch that never should have existed as filed. The May 2026 rule responds with more specific batching criteria and a hard cap of 50 line items per dispute. That cap is an implicit admission that loose batching practices, especially among high volume anesthesiology, radiology, pathology, and lab filers, had become routine enough to need a structural fix rather than case-by-case correction.

Where specialty still genuinely matters

None of this erases specialty-level distinctions. It just relocates where they matter most. Ground ambulance services were excluded from the No Surprises Act altogether, so no federal IDR pathway exists for them regardless of how clean the claim otherwise is; air ambulance services, by contrast, have their own dedicated federal IDR track. Emergency medicine carries a procedural split worth knowing: services before stabilization can never be waived, and post-stabilization services can only be waived under narrow, specific conditions. That split matters practically because emergency room care accounts for roughly two out of every three disputed services filed in the federal system. And the batching rules above apply differently by specialty, with anesthesiology, radiology, pathology, and lab claims now following a distinct grouping standard built around CPT Category I sections. The specialty differences that matter in 2026 are procedural ones, not consent-form ones.

The questions worth asking before the next open negotiation notice goes out

Does the practice have a way to confirm, before filing, that the specific rendering provider, not just the group TIN, actually lacked a contract with that payer for that claim? Is the open negotiation period being documented through the portal with a real response on record, rather than assumed to have run its course? Has anyone checked whether the state and plan type in question route this claim to a state dispute process instead of the federal one? And is the batch being filed built around a grouping rule that would hold up, or around administrative convenience?

Getting these answers right before initiating open negotiation, not after a certified IDR entity returns an ineligibility notice, is the difference between building a case and burning time and administrative fees on one that was never eligible to begin with.

‍